EU nod for Libtayo plus chemo for advanced PD-L1 positive NSCLC

  • Israel Lowy,

Press/Media

Period29 Mar 2023

Media coverage

1

Media coverage

  • TitleEU nod for Libtayo plus chemo for advanced PD-L1 positive NSCLC
    Media name/outletPharma Marketletter
    Country/TerritoryUnited Kingdom
    Date29/03/23
    PersonsIsrael Lowy,